Skip to main content
Clinical Trials/EUCTR2012-003875-20-SE
EUCTR2012-003875-20-SE
Active, not recruiting
Phase 1

Postoperative pain relief following total hip arthroplasty. A comparison between 3-in-1 blockade (single shot) with ultrasound placement and local infiltration analgesia.

niversitetssjukhuset Örebro0 sitesDecember 3, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postoperative pain relief after total hip arthroplasty
Sponsor
niversitetssjukhuset Örebro
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2012
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversitetssjukhuset Örebro

Eligibility Criteria

Inclusion Criteria

  • 1\. 50 \- 80 year\-old patient undergoing total hip arthroplasty.
  • 2\. ASA I – III
  • 3\. Signed and dated Informed Consent.
  • 4\. The patient is willing and able to comply with the protocol
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 0
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • 1\. Re\-operation of a previous total hip arthroplasty.
  • 2\. Allergy/intolerance to local anaesthetics, Morphine, Adrenaline, Ketorolac or Ropivacaine.
  • 3\. Serious liver\- or renal disease judged by the investigator to be of such dignity as to prevent inclusion into the study.
  • 4\. Serious heart disease judged by the investigator to be of such dignity as to prevent inclusion into the study,
  • 5\. Patients with chronic pain who are taking opiate analgesics regularly.
  • 6\. Major bleeding disorders
  • 7\. Chronic obstructive pulmonary disease (COPD)
  • 8\. Severe asthma that is difficult to treat
  • 9\. Limited breathing capacity due to muscular dystrophy
  • 10\. Sleep apnoea syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials